Related Experiment Video
Updated: Feb 24, 2026

09:43
Measurement of Heme Synthesis Levels in Mammalian Cells
Published on: July 9, 2015
12.6K
[Hfeprotein impact on iron metabolism]
Barbara Kaczorowska-Hać1, Jan Jacek Kaczor2
1Zakład Terapii Zajęciowej, Akademia Wychowania Fizycznego i Sportu w Gdańsku, Polska.
Developmental Period Medicine
|August 11, 2017
Summary
Hereditary hemochromatosis type 1, caused by HFE gene mutations, affects iron metabolism. This review explores the impact of these mutations on children, as their effects are not well understood.
Area of Science:
- Genetics
- Pediatrics
- Metabolic Disorders
Background:
- Hereditary hemochromatosis type 1 is an autosomal recessive disorder.
- It results from mutations in the HFE gene, a key regulator of iron homeostasis.
- Clinical manifestations in adults, primarily males, stem from iron overload in organs and are influenced by individual and environmental factors.
Purpose of the Study:
- To review existing literature on the role and impact of HFE gene mutations in children.
- To elucidate the effects of HFE variants on pediatric iron metabolism and health outcomes.
Main Methods:
- Literature review of studies concerning HFE gene mutations and hereditary hemochromatosis type 1.
- Analysis of research focusing on the pediatric population.
Main Results:
- HFE gene variants are widespread, but their specific impact, particularly in children, remains largely unknown.
- Phenotypic expression of hereditary hemochromatosis type 1 is highly variable, influenced by genetic and environmental factors.
Conclusions:
- Further research is needed to understand the full spectrum of HFE gene mutation effects in children.
- Clarifying the impact of HFE variants in pediatric populations is crucial for early diagnosis and management.
Related Concept Videos
The Early Endosome: Endocytosis of Transferrin
4.9K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
4.9K
Factors Affecting Erythropoiesis
6.3K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
6.3K
Lifecycle of Erythrocytes
5.5K
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
5.5K
Role of Hematopoietic Growth Factors
4.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
4.1K
Erythropoiesis
6.3K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
6.3K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
294
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
294

